After ExOne announced a $13M stock investment financed through its CEO and an at-the-money stock issuance for up to $50M to be exercised at ExOne's discretion and the stock fell 13%, Oppenheimer says that the decline in the stock "was grossly overdone." The firm says that the shares will only be "lightly tapped" unless the company's business improves, and it thinks the CEO's decision may indicate that the company raised the funds because its business is improving. Oppenheimer says that "at the very least," the moves will allow the company to remain solvent for a significantly longer time. It keeps a $14 price target and Outperform rating on the shares.